Short and long-term effect of dexamethasone on the transcriptome profile of primary human trabecular meshwork cells in vitro

[1]  C. Willoughby,et al.  A Comparative Genome-Wide Transcriptome Analysis of Glucocorticoid Responder and Non-Responder Primary Human Trabecular Meshwork Cells , 2021, bioRxiv.

[2]  Hannah C. Webber,et al.  Full title: The canonical Wnt signaling pathway inhibits the glucocorticoid receptor signaling pathway in the trabecular meshwork. , 2021, The American journal of pathology.

[3]  V. K. Raghunathan,et al.  Glucocorticoid-induced cell-derived matrix modulates transforming growth factor β2 signaling in human trabecular meshwork cells , 2020, Scientific Reports.

[4]  Jingyi Zhu,et al.  Rottlerin acts as a therapeutic in primary open-angle glaucoma by targeting the trabecular meshwork via activation of Rap1 signaling. , 2020, Pharmacological research.

[5]  C. Evelo,et al.  The Molecular Processes in the Trabecular Meshwork After Exposure to Corticosteroids and in Corticosteroid-Induced Ocular Hypertension , 2020, Investigative ophthalmology & visual science.

[6]  Di Chen,et al.  Characteristic Cytokine Profiles of Aqueous Humor in Glaucoma Secondary to Sturge-Weber Syndrome , 2020, Frontiers in Immunology.

[7]  Steven L Salzberg,et al.  Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype , 2019, Nature Biotechnology.

[8]  M. Rivas,et al.  Rare protein-altering variants in ANGPTL7 lower intraocular pressure and protect against glaucoma , 2019, bioRxiv.

[9]  M. Filla,et al.  Genomic/proteomic analyses of dexamethasone-treated human trabecular meshwork cells reveal a role for GULP1 and ABR in phagocytosis , 2019, Molecular vision.

[10]  P. Kaufman,et al.  SB772077B, A New Rho Kinase Inhibitor Enhances Aqueous Humour Outflow Facility in Human Eyes , 2018, Scientific Reports.

[11]  K. Lester.  Reverse Engineering Glaucoma , 2018 .

[12]  C. R. Ethier,et al.  Consensus recommendations for trabecular meshwork cell isolation, characterization and culture. , 2018, Experimental eye research.

[13]  Y. Hata,et al.  The RASSF6 Tumor Suppressor Protein Regulates Apoptosis and Cell Cycle Progression via Retinoblastoma Protein , 2018, Molecular and Cellular Biology.

[14]  Wen Zhang,et al.  Research progress on human genes involved in the pathogenesis of glaucoma , 2018, Molecular medicine reports.

[15]  Zhengping Xu,et al.  The emerging role of follistatin under stresses and its implications in diseases. , 2018, Gene.

[16]  Hannah C. Webber,et al.  A Comparison of Gene Expression Profiles between Glucocorticoid Responder and Non-Responder Bovine Trabecular Meshwork Cells Using RNA Sequencing , 2017, PloS one.

[17]  M. Cecchini,et al.  Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease , 2016, Scientific Reports.

[18]  Herbert Yu,et al.  Complement component 7 (C7), a potential tumor suppressor, is correlated with tumor progression and prognosis , 2016, Oncotarget.

[19]  Hannah C. Webber,et al.  Crosstalk between TGFβ and Wnt signaling pathways in the human trabecular meshwork. , 2016, Experimental eye research.

[20]  Zhengping Xu,et al.  Transcriptional activation of follistatin by Nrf2 protects pulmonary epithelial cells against silica nanoparticle-induced oxidative stress , 2016, Scientific Reports.

[21]  Joshua T. Morgan,et al.  Dexamethasone Stiffens Trabecular Meshwork, Trabecular Meshwork Cells, and Matrix. , 2015, Investigative ophthalmology & visual science.

[22]  A. Murakami,et al.  DNA Methylation Analysis of Human Trabecular Meshwork Cells During Dexamethasone Stimulation. , 2015, Investigative ophthalmology & visual science.

[23]  C. Sobey,et al.  Activin and NADPH-oxidase in preeclampsia: insights from in vitro and murine studies. , 2015, American journal of obstetrics and gynecology.

[24]  V. Schuster,et al.  The Prostaglandin Transporter: Eicosanoid Reuptake, Control of Signaling, and Development of High-Affinity Inhibitors as Drug Candidates. , 2015, Transactions of the American Clinical and Climatological Association.

[25]  T. Borrás.  The effects of myocilin expression on functionally relevant trabecular meshwork genes: a mini-review. , 2014, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[26]  Wei Shi,et al.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..

[27]  C. Cavadas,et al.  Neuropeptide Y receptors activation protects rat retinal neural cells against necrotic and apoptotic cell death induced by glutamate , 2013, Cell Death and Disease.

[28]  A. Clark,et al.  The effects of transforming growth factor-β2 on the expression of follistatin and activin A in normal and glaucomatous human trabecular meshwork cells and tissues. , 2012, Investigative ophthalmology & visual science.

[29]  T. Borrás,et al.  Evidence for a role of angiopoietin‐like 7 (ANGPTL7) in extracellular matrix formation of the human trabecular meshwork: implications for glaucoma , 2011, Genes to cells : devoted to molecular & cellular mechanisms.

[30]  R. Greil,et al.  PLZF/ZBTB16, a glucocorticoid response gene in acute lymphoblastic leukemia, interferes with glucocorticoid-induced apoptosis , 2010, Journal of Steroid Biochemistry and Molecular Biology.

[31]  H. Glaeser,et al.  The prostaglandin transporter OATP2A1 is expressed in human ocular tissues and transports the antiglaucoma prostanoid latanoprost. , 2010, Investigative ophthalmology & visual science.

[32]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[33]  E. Lobenhofer,et al.  Glucocorticoids with different chemical structures but similar glucocorticoid receptor potency regulate subsets of common and unique genes in human trabecular meshwork cells , 2009, BMC Medical Genomics.

[34]  P. Russell,et al.  Gene expression profiling of TGFbeta2- and/or BMP7-treated trabecular meshwork cells: Identification of Smad7 as a critical inhibitor of TGF-beta2 signaling. , 2009, Experimental eye research.

[35]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[36]  J. Kuchtey,et al.  Angiopoietin-like 7 secretion is induced by glaucoma stimuli and its concentration is elevated in glaucomatous aqueous humor. , 2008, Investigative ophthalmology & visual science.

[37]  Chi Pui Pang,et al.  Gene Expression Profiles of Human Trabecular Meshwork Cells Induced by Triamcinolone and Dexamethasone Methods Cell Culture and Treatment , 2022 .

[38]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[39]  Olivera Stojadinovic,et al.  Novel Genomic Effects of Glucocorticoids in Epidermal Keratinocytes , 2006, Journal of Biological Chemistry.

[40]  D. Rhee,et al.  Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature. , 2006, Current opinion in ophthalmology.

[41]  J. Hoheisel.  Microarray technology: beyond transcript profiling and genotype analysis , 2006, Nature Reviews Microbiology.

[42]  M. Othman,et al.  Gene expression profile of human trabecular meshwork cells in response to long-term dexamethasone exposure. , 2006, Molecular vision.

[43]  C. R. Ethier,et al.  Dexamethasone alters F-actin architecture and promotes cross-linked actin network formation in human trabecular meshwork tissue. , 2005, Cell motility and the cytoskeleton.

[44]  Chi Pui Pang,et al.  The dual role of dexamethasone on anti-inflammation and outflow resistance demonstrated in cultured human trabecular meshwork cells. , 2003, Molecular vision.

[45]  M. Hernandez,et al.  Tissue differential microarray analysis of dexamethasone induction reveals potential mechanisms of steroid glaucoma. , 2003, Investigative ophthalmology & visual science.

[46]  Takeshi Ishibashi,et al.  Cdna Microarray Analysis of Gene Expression Changes Induced by Dexamethasone in Cultured Human Trabecular Meshwork Cells Materials and Methods Cell Culture , 2022 .

[47]  A. Clark,et al.  Expression of bone morphogenetic proteins (BMP), BMP receptors, and BMP associated proteins in human trabecular meshwork and optic nerve head cells and tissues. , 2002, Molecular vision.

[48]  Douglas H. Johnson,et al.  Dexamethasone decreases phagocytosis by human trabecular meshwork cells in situ. , 1997, Investigative ophthalmology & visual science.

[49]  C. Y. Chen,et al.  AU-rich elements: characterization and importance in mRNA degradation. , 1995, Trends in biochemical sciences.

[50]  V. Schuster,et al.  Identification and characterization of a prostaglandin transporter. , 1995, Science.

[51]  Stuart K. Williams,et al.  Isolation and culture of human trabecular meshwork cells by extracellular matrix digestion. , 1995, Current eye research.

[52]  A. Clark,et al.  Glucocorticoid-induced formation of cross-linked actin networks in cultured human trabecular meshwork cells. , 1994, Investigative ophthalmology & visual science.

[53]  N. Yoshimura,et al.  Neuropeptide-induced [Ca2+]i transients in cultured bovine trabecular cells. , 1992, Investigative ophthalmology & visual science.

[54]  M. Gerritsen,et al.  Dexamethasone induces specific proteins in human trabecular meshwork cells. , 1989, Investigative ophthalmology & visual science.

[55]  E. Shohami,et al.  Effect of Dexamethasone on Prostaglandin Synthesis in Various Areas of the Rat Brain , 1987, Journal of neurochemistry.

[56]  P. Emson,et al.  Neuropeptide Y and the ocular innervation of rat, guinea pig, cat and monkey , 1986, Neuroscience.

[57]  R. Tripathi,et al.  Ultrastructure of the exit pathway of the aqueous in lower mammals. (A preliminary report on the "angular aqueous plexus"). , 1971, Experimental eye research.

[58]  B. Becker,et al.  CORTICOSTEROIDS AND INTRAOCULAR PRESSURE. , 1963, Archives of ophthalmology.

[59]  B. Becker,et al.  Steroid-induced elevation of intraocular pressure. , 1963, Archives of ophthalmology.

[60]  D. M. Gordon.  Prednisone and prednisolone in ocular disease. , 1956, American journal of ophthalmology.